US Patent Issued to Oyster Point Pharma on June 16 for "Compositions and use of varenicline for treating dry eye" (Nevada, Massachusetts, Texas Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,824, issued on June 16, was assigned to Oyster Point Pharma Inc. (Morgantown, W.va.). "Compositions and use of varenicline for treating dry... Read More

US Patent Issued to The Trustees of Columbia University in the City of New York on June 16 for "Aldose reductase inhibitors and uses thereof" (New York, Connecticut, New Jersey Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,825, issued on June 16, was assigned to The Trustees of Columbia University in the City of New York (New York). "Aldose reductase inhibitor... Read More

US Patent Issued to TerSera Therapeutics on June 16 for "Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors" (Illinois, Oregon Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,826, issued on June 16, was assigned to TerSera Therapeutics LLC (Deerfield, Ill.). "Methods of reducing the likelihood of carcinoid heart ... Read More

US Patent Issued to Telios Pharma on June 16 for "Methods of treating indolent systemic mastocytosis" (California, Florida Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,827, issued on June 16, was assigned to Telios Pharma Inc. (Redwood City, Calif.). "Methods of treating indolent systemic mastocytosis" was... Read More

US Patent Issued to AstraZeneca on June 16 for "POLQ inhibitors" (British, American Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,828, issued on June 16, was assigned to AstraZeneca AB (Sodertalje, Sweden). "POLQ inhibitors" was invented by Bernard Barlaam (Cambridge, ... Read More

US Patent Issued to Nammi Therapeutics on June 16 for "Formulated and/or co-formulated compositions containing A2aR antagonist prodrugs useful in the treatment of cancer and methods thereof" (California, New York Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,829, issued on June 16, was assigned to Nammi Therapeutics Inc. (Los Angeles). "Formulated and/or co-formulated compositions containing A2a... Read More

US Patent Issued to Impact Therapeutics (Shanghai) on June 16 for "Substituted imidazoquinoxaline compounds and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,830, issued on June 16, was assigned to Impact Therapeutics (Shanghai) Inc (Shanghai). "Substituted imidazoquinoxaline compounds and uses t... Read More

US Patent Issued to DemeRx on June 16 for "Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids" (Florida Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,831, issued on June 16, was assigned to DemeRx Inc. (Miami). "Methods for the non-toxic treatment for opioid drug withdrawal combining nori... Read More

US Patent Issued to Brigham Young University on June 16 for "Methods for treating lung infections and inflammation" (Utah, Ohio, Nevada Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,832, issued on June 16, was assigned to Brigham Young University (Provo, Utah). "Methods for treating lung infections and inflammation" was... Read More

US Patent Issued to GLENMARK SPECIALTY on June 16 for "Nasal spray composition" (Indian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,833, issued on June 16, was assigned to GLENMARK SPECIALTY S.A. (Neuchatel, Switzerland). "Nasal spray composition" was invented by Ulhas D... Read More

• ««
• «
• 168381
• 168382
• 168383
• 168384
• 168385
• 168386
• 168387
• 168388
• 168389
• 168390
• »
• »»